- Tytuł:
- 1054P A phase Ia study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of a modular CLDN18.2-targeting PG CAR-T therapy (IBI345) in patients with CLDN18.2+ solid tumors
- Autorzy:
- Źródło:
- In Annals of Oncology October 2023 34 Supplement 2:S638-S638
Czasopismo naukowe